EMAIL EMAIL
ANALYST BRIEFING
Title: Analyst Briefing: Are Biosimilars the Road to Certain Success or a High-Risk Venture?
Analyst: Deborah Toscano
Briefing Date: Oct 17 2013
Time: 1:00pm EDT/12:00pm CDT/6:00pm BST/7:00pm CEST

You Will Discover:

The biosimilars market is on the verge of transitioning from a state of infancy to an entrenched facet of healthcare.  Numerous biosimilars, or follow-on biologics, have been successfully launched in many countries outside the U.S. Lower cost biosimilar versions of more complex biologic therapies, such as monoclonal antibodies, are now eagerly awaited and  expected to significantly impact healthcare costs, particularly in the U.S., the largest market for biotechnology. However, residual uncertainties surrounding approval and commercial uptake could considerably influence the true potential of this market.

Why You Should Attend:

• Discover the issues around regulatory and payer acceptance of biosimilars in the U.S.
• Learn how biosimilars are forecast to penetrate various biopharmaceutical segments and therapeutic areas
• Understand the potential risks and rewards of this market
• Gain insight into the competitive environment and potential U.S. market leaders
• Identify the key factors with potential to impact the uptake of biosimilars

Registration:

Click on the "Play" button below to listen on demand.

BACK TO TOP BACK TO TOP

QUICK SEARCH

GO GO
ADVANCED SEARCH
Search our research by date, market, technology, region or keywords
GO GO
SHARE
Discover how we can help your business
GO  GO
Learn how we can provide data and insight for your specific requirements
GO  GO
HELP DESK
For general assistance and enquiries:
Africa:
+27 21 680 3260
enquiries@frost.com

Asia Pacific:
+65 68900999
apacfrost@frost.com

Europe:
+44 (0)20 8996 8500
enquiries@frost.com

Israel:
+972-9-9502888
Israel@frost.com

Latin America:
+54 11 4777 1550
myfrost@frost.com

Middle East & North Africa:
+971.4.4331.893
meenquiries@frost.com

North America:
+1.877.463.7678
myfrost@frost.com

South Asia:
+91 (0) 22 6160 6666
saenquiries@frost.com

For a full list of our offices click here
Sitemap | Disclaimer | Privacy
© Frost & Sullivan
Conseq